| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 13 | +23.08% | -0.57% | +0.03% | -0.60% | -1.84% | — |
| 14d | 13 | +46.15% | +12.54% | -0.57% | +13.11% | -3.05% | — |
| 30d | 13 | +15.38% | -7.12% | +1.45% | -8.57% | -26.82% | — |
| 60d | 13 | +23.08% | -19.15% | +2.90% | -22.06% | -35.50% | — |
| 90d | 13 | +15.38% | -29.80% | +3.19% | -32.99% | -36.35% | — |
| 180d | 13 | +15.38% | -27.55% | +6.98% | -34.53% | -28.22% | — |
| 1y | 13 | +0.00% | -70.47% | +15.55% | -86.02% | -91.90% | — |
| 2y | 13 | +0.00% | -86.73% | +26.77% | -113.50% | -120.34% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| VVOS VIVOS THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 315,421 | $2.64 | $832.7K | 364,755 | Nov 26, 2024 | Nov 27, 2024 ↗ | View → |
| VVOS VIVOS THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 20,000 | $2.38 | $47.6K | 49,334 | Jun 20, 2024 | Jun 28, 2024 ↗ | View → |
| VVOS VIVOS THERAPEUTICS, INC. | PURCHASE Chief Executive Officer | 14,000 | $0.53 | $7.4K | 86,521 | Jun 20, 2023 | Jun 20, 2023 ↗ | View → |
| VVOS VIVOS THERAPEUTICS, INC. | PURCHASE Chief Executive Officer | 5,000 | $0.53 | $2.6K | 72,521 | Jun 16, 2023 | Jun 20, 2023 ↗ | View → |
| VVOS VIVOS THERAPEUTICS, INC. | PURCHASE Chief Executive Officer | 10,000 | $0.54 | $5.4K | 67,521 | Jun 16, 2023 | Jun 20, 2023 ↗ | View → |
| VVOS VIVOS THERAPEUTICS, INC. | PURCHASE Chief Executive Officer | 21 | $0.50 | $11 | 57,521 | Jun 15, 2023 | Jun 20, 2023 ↗ | View → |
| VVOS VIVOS THERAPEUTICS, INC. | PURCHASE Chief Executive Officer | 10,000 | $0.49 | $4.9K | 57,500 | Jun 14, 2023 | Jun 15, 2023 ↗ | View → |
| VVOS VIVOS THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 333,334 | $0.48 | $160.0K | 333,334 | Dec 23, 2022 | Dec 28, 2022 ↗ | View → |
| VVOS VIVOS THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 150,000 | $0.48 | $72.0K | 483,334 | Dec 23, 2022 | Dec 28, 2022 ↗ | View → |
| VVOS VIVOS THERAPEUTICS, INC. | PURCHASE Chief Executive Officer | 20,000 | $0.50 | $10.0K | 47,500 | Dec 23, 2022 | Dec 28, 2022 ↗ | View → |
| VVOS VIVOS THERAPEUTICS, INC. | PURCHASE Chief Executive Officer | 4,000 | $1.83 | $7.3K | 27,500 | Jun 1, 2022 | Jun 3, 2022 ↗ | View → |
| VVOS VIVOS THERAPEUTICS, INC. | PURCHASE Chief Executive Officer | 8,000 | $2.03 | $16.2K | 23,500 | May 31, 2022 | Jun 3, 2022 ↗ | View → |
| VVOS VIVOS THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 125,000 | $3.27 | $408.8K | 125,000 | Feb 25, 2022 | Feb 28, 2022 ↗ | View → |
| VVOS VIVOS THERAPEUTICS, INC. | PURCHASE Chief Executive Officer | 5,000 | $4.31 | $21.6K | 15,500 | Sep 21, 2021 | Sep 22, 2021 ↗ | View → |
| VVOS VIVOS THERAPEUTICS, INC. | PURCHASE Chief Executive Officer | 5,000 | $3.00 | $15.0K | 10,500 | Aug 17, 2021 | Aug 18, 2021 ↗ | View → |
| VVOS VIVOS THERAPEUTICS, INC. | PURCHASE Chief Executive Officer | 4,000 | $5.38 | $21.5K | 5,500 | May 25, 2021 | May 25, 2021 ↗ | View → |
| VVOS VIVOS THERAPEUTICS, INC. | PURCHASE Chief Executive Officer | 1,000 | $7.27 | $7.3K | 1,500 | Dec 23, 2020 | Dec 23, 2020 ↗ | View → |
| VVOS VIVOS THERAPEUTICS, INC. | PURCHASE Chief Executive Officer | 500 | $8.50 | $4.3K | 500 | Dec 11, 2020 | Dec 14, 2020 ↗ | View → |